Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters








Database
Language
Publication year range
1.
Front Plant Sci ; 13: 988647, 2022.
Article in English | MEDLINE | ID: mdl-36212380

ABSTRACT

Fruit branch angle (FBA), a pivotal component of cotton plant architecture, is vital for field and mechanical harvesting. However, the molecular mechanism of FBA formation is poorly understood in cotton. To uncover the genetic basis for FBA formation in cotton, we performed a genome-wide association study (GWAS) of 163 cotton accessions with re-sequencing data. A total of 55 SNPs and 18 candidate genes were significantly associated with FBA trait. By combining GWAS and transcriptome analysis, four genes underlying FBA were identified. An FBA-associated candidate gene Ghi_A09G08736, which is homologous to SAUR46 in Arabidopsis thaliana, was detected in our study. In addition, transcriptomic evidence was provided to show that gravity and light were implicated in the FBA formation. This study provides new insights into the genetic architecture of FBA that informs architecture breeding in cotton.

2.
Genet Test Mol Biomarkers ; 16(1): 63-6, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21819245

ABSTRACT

Prior studies investigating the association between apolipoprotein E (APOE) gene polymorphism and the risk of intracerebral hemorrhage (ICH) have been inconsistent and limited to small sample sizes. The aim of this study was to test the hypothesis that APOE gene polymorphisms are associated with the risk of ICH in Chinese Han patients. We enrolled 180 ICH patients and 180 controls. APOE genotype was determined by using a polymerase chain reaction-restriction fragment length polymorphism assay. ICH patients had a significantly lower frequency ɛ3/ɛ3 [odds ratio (OR)=0.45, 95% confidence interval (CI)=0.28, 0.71; p=0.001] and ɛ3 allele (OR=0.51, 95% CI=0.35, 0.76; p=0.001) than healthy controls. ICH patients also had a significantly higher frequency ɛ3/ɛ4 (OR=3.61, 95% CI=1.89, 6.88; p<0.001) and ɛ4 allele (OR=3.00, 95% CI=1.76, 5.13; p<0.001) than healthy controls. This study suggests that the APOE genotype is associated with the risk of ICH in Chinese Han patients.


Subject(s)
Apolipoproteins E/genetics , Asian People/genetics , Cerebral Hemorrhage/genetics , Polymorphism, Genetic , Aged , Alleles , Case-Control Studies , Cerebral Hemorrhage/epidemiology , Cerebral Hemorrhage/ethnology , Female , Genetic Predisposition to Disease , Genetics, Population , Genotype , Humans , Male , Middle Aged , Polymorphism, Genetic/physiology , Polymorphism, Restriction Fragment Length , Risk Factors
3.
Life Sci ; 78(22): 2564-70, 2006 Apr 25.
Article in English | MEDLINE | ID: mdl-16321402

ABSTRACT

Stroke is one of the leading causes of mortality; however, its treatment remains obscure and largely empirical. Since matrix metalloproteinase 9 (MMP-9) has been postulated to be the major contributor of neuronal injury during reperfusion, inhibition of MMP-9 could be a potential approach in maintaining the viability of neurons. Trans-resveratrol (resveratrol), a polyphenolic compound has recently been shown to have neuroprotective activity against cerebral ischemia. Therefore, the aim of the present study was to evaluate the effect of resveratrol on MMP-9 induced by cerebral ischemia-reperfusion in vivo. Male Balb/C mice were treated with resveratrol for 7 days (50 mg/kg, gavage). Thereafter, middle cerebral artery occlusion (MCAo) was performed for 2 h with the help of intraluminal thread. Drug-treated mice showed improvement in necrotic changes in cortex and basal ganglia. Detection of MMP-9 activity and gene expression was performed at various time points after MCAo. The elevated levels of MMP-9 were significantly attenuated in the resveratrol-treated mice as compared to the vehicle MCAo mice. The study suggests that resveratrol has protective effects against acute ischemic stroke, which could be attributed to its property against MMP-9. Thus, resveratrol may be a potential agent for the treatment of neuronal injury associated with stroke.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Ischemic Attack, Transient/drug therapy , Matrix Metalloproteinase 9/metabolism , Neuroprotective Agents/therapeutic use , Reperfusion Injury/prevention & control , Stilbenes/therapeutic use , Stroke/drug therapy , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Disease Models, Animal , Gene Expression , Ischemic Attack, Transient/metabolism , Ischemic Attack, Transient/pathology , Male , Matrix Metalloproteinase 9/genetics , Mice , Mice, Inbred BALB C , RNA, Messenger/metabolism , Reperfusion Injury/pathology , Resveratrol , Reverse Transcriptase Polymerase Chain Reaction , Stroke/metabolism , Stroke/pathology
SELECTION OF CITATIONS
SEARCH DETAIL